NCT04439825View on ClinicalTrials.gov

Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 20, 2020

Primary Completion Date

September 3, 2020

Study Completion Date

December 1, 2020

Conditions
Mood
Interventions
DRUG

Botulinum Neurotoxin

glabella, forehead lines and/or lateral canthal lines

DRUG

Placebo

Saline solution (preservative free)

Trial Locations (1)

60611

DeNova Research, Chicago

Sponsors

Lead Sponsor

DeNova Research
All Listed Sponsors
lead

DeNova Research

OTHER